Does Aspirin Increase Survival for Breast Cancer Patients?

In some cases, breast cancer patients who were aspirin users before diagnosis have been shown to live longer than those who did not take aspirin before diagnosis. However, for other breast cancer patients, the reverse is true; they have an increased risk of death from their aspirin use than those who do not use aspirin. According to a recent study, researchers have discovered why some breast cancer patients benefit from aspirin use and why for others, aspirin increases mortality risk: DNA methyl...
Continue reading

Early Breast Cancer in Older Patients: Standard Chemotherapy Versus Capecitabine

In older women with early breast cancer, standard adjuvant chemotherapy is superior to capecitabine for recurrence-free survival. These results come from the 10-year follow-up of the Cancer and Leukemia Group B (CALGB) 49907 trial, which focused on patients age 65 and older. For this study, 633 patients were randomized to receive either standard adjuvant chemotherapy, consisting of physician's choice of cyclophosphamide/methotrexate/fluorouracil or cyclophosphamide/doxorubicin, or capecitabine. ...
Continue reading

Disparities Among Patients With Triple-Negative Breast Cancer

Historically, triple-negative breast cancer (TNBC), a disease that tests negative for estrogen, progesterone, and human epidermal growth factor receptors, is more aggressive and carries a worse prognosis than most other types of breast cancer. Researchers conducted a study to understand risk factors that cause disparities in diagnosis in order to develop preventive measures for TNBC and found that women of color and younger women are most at risk of developing TNBC. For this study, published in ...
Continue reading

Radioactive Iodine for Hyperthyroidism: Link to Cancer Mortality With Cari M. Kitahara, PhD, MHS

​ Radioactive iodine is commonly used to treat hyperthyroidism, such as that which results from Graves disease. However, Cari M. Kitahara, PhD, MHS, and colleagues report that this treatment is associated with cancer mortality and that higher doses are associated with greater risk of death from solid cancers, including female breast cancer. In this interview with i3 Health, Dr. Kitahara, Investigator of the Radiation Epidemiology Branch of the National Cancer Institute's Division of Cancer Epide...
Continue reading

Treatment for Hyperthyroidism Linked to Cancer Deaths

​ Treatment for hyperthyroidism that uses radioactive iodine (RAI) is associated with mortality from solid cancers, particularly breast cancer, reports a new study published in JAMA Internal Medicine . Hyperthyroidism affects 1.2% of the US population, with most cases attributed to Graves disease. Since the 1940s, radioactive iodine (RAI), more specifically sodium iodide I 131, has been widely used to treat hyperthyroidism. In recent years, its use as a primary treatment for Graves disease has d...
Continue reading

© Copyright 2019 i3 Health. All rights reserved.